MediTechX is projected to rise to $0.0771 by 2027, a +50% move from its current price of $0.0515. MTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $0.0515 | $0.0516 | $0.0517 | +0.15% |
| Aug 3 | $0.0515 | $0.0517 | $0.0519 | +0.30% |
| Aug 4 | $0.0515 | $0.0517 | $0.052 | +0.44% |
| Aug 5 | $0.0515 | $0.0518 | $0.0521 | +0.59% |
| Aug 6 | $0.0516 | $0.0519 | $0.0522 | +0.74% |
| Aug 7 | $0.0516 | $0.052 | $0.0523 | +0.89% |
| Aug 8 | $0.0517 | $0.0521 | $0.0524 | +1.04% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0517 | $0.0521 | $0.0524 | +1.04% |
| Week 2 | $0.0521 | $0.0526 | $0.0531 | +2.09% |
| Week 3 | $0.0525 | $0.0531 | $0.0538 | +3.15% |
| Week 4 | $0.0529 | $0.0537 | $0.0545 | +4.22% |
| Week 5 | $0.0534 | $0.0542 | $0.0551 | +5.30% |
| Week 6 | $0.0539 | $0.0548 | $0.0558 | +6.40% |
| Week 7 | $0.0544 | $0.0554 | $0.0564 | +7.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MeditechX (MTX) is a health-technology ecosystem that integrates artificial intelligence, IoT wearables, and blockchain to improve daily wellness, activity tracking, and long-term healthcare management. The project aims to create a smarter, more connected health environment where users can monitor their bodies in real time, protect their medical data, and earn meaningful rewards for leading a healthier lifestyle. The MTX token functions as the ecosystem’s utility asset, supporting rewards, staking, in-app services, and access to premium features.
MTX features an Exercise-to-Earn (E2E) model that connects users’ real-world physical activity to digital rewards. By using wearable sensors and AI-powered analytics, MTX transforms daily healthy actions, workouts, and vital-sign monitoring into a personalized health score. Blockchain technology is used to enhance data integrity, transparency, and user ownership, ensuring that individuals remain in full control of their health information.
MTX is currently priced at $0.0515. Its market cap stands at $1.39M, and it is ranked 2509 by market capitalization. The price sits in a market with a bullish technical sentiment and a 30-day range between $0.0508 and $0.0522, with a support level at $0.0507 and a resistance at $0.0516.
Forecasts project a path of rising averages over the coming years, beginning with a 2026 avg of $0.0515 and moving toward higher levels such as 2030 avg $0.1688, 2040 avg $0.6029, and 2050 avg $0.9625. The sentiment shifts from NEUTRAL in 2026 to BULLISH from 2027 onward, with positive ROI trajectories in later years (e.g., 2027 65.3%, 2029 97%, 2030 227.8%, 2040 1070.6%, 2050 1768.8%).
These projections provide a long-horizon view of MTX price dynamics, but they are estimates and not guarantees. Investors should consider the variability inherent in small-cap crypto assets and the broader market environment when evaluating future potential.
A major floor 2.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.7% away) — a key level to hold.
Price is pressing into resistance (0.2% away) — a breakout level to watch.
A major ceiling 1.3% above — clearing it would confirm fresh momentum.
Key MTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0515 | Buy | $0.0515 | Buy |
| MA 10 | $0.0513 | Buy | $0.0514 | Buy |
| MA 20 | $0.0513 | Buy | $0.0513 | Buy |
| MA 50 | $0.051 | Buy | $0.0511 | Buy |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.67 | Neutral |
| Stoch RSI (14) | 56.36 | Neutral |
| CCI (20) | 125.38 | Buy |
| Williams %R (14) | -21.75 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 0.75 | Buy |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 78.25 | Neutral |
| TRIX (15) | 0.03 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 64.82 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 0.05 | Sell |
| ADX (14) | 16.55 | Neutral |
| ATR (14) | 0.00 | Info |
The near-term technical picture is bullish, with RSI(14) at 60 and the price hovering near the 50-day simple moving average at $0.051. The 30-day price range spans from $0.0508 to $0.0522, indicating a tight trading band around the current level.
Support is at $0.0507 and resistance at $0.0516, positioning the price to bounce within a narrow channel. The current price of $0.0515 sits close to the SMA50, suggesting limited downside pressure if the price remains above the support level. Annualized volatility is modest at 5%, adding a measured layer of risk to the near-term outlook.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0505 | $0.0515 | $0.0861 | 0% | Neutral | |
| $0.0613 | $0.0771 | $0.1027 | +50% | Bullish | |
| $0.0633 | $0.082 | $0.1135 | +59% | Bullish | |
| $0.0761 | $0.101 | $0.144 | +96% | Bullish | |
| $0.1108 | $0.1502 | $0.2198 | +192% | Bullish | |
| $0.1358 | $0.1877 | $0.2807 | +264% | Bullish | |
| $0.1142 | $0.1608 | $0.2453 | +212% | Bullish | |
| $0.1533 | $0.2195 | $0.3407 | +326% | Bullish | |
| $0.2324 | $0.3383 | $0.5338 | +557% | Bullish | |
| $0.1878 | $0.2776 | $0.4447 | +439% | Bullish | |
| $0.3703 | $0.5871 | $1.00 | +10.4x | Bullish | |
| $0.5452 | $0.9761 | $1.83 | +17.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.0505 | $0.0515 | $0.0671 | +0.00% |
| September 2026 | $0.0464 | $0.0549 | $0.0669 | +6.58% |
| October 2026 | $0.0494 | $0.0589 | $0.0726 | +7.35% |
| November 2026 | $0.0556 | $0.0667 | $0.0829 | +13.16% |
| December 2026 | $0.057 | $0.0687 | $0.0861 | +3.02% |
Click any year to see its month-by-month MTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MTX could reach as high as $0.0861, with a base case around $0.0515 and support toward $0.0505 — roughly 0% from $0.0515. Price action looks broadly range-bound.
Expect MTX to range from $0.0613 to $0.1027 through 2027. The $0.0771 average target implies a +50% move from current prices. That is up +50% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The MTX price prediction for 2028 points to an average of $0.082 (low $0.0633, high $0.1135) — a potential gain of +59% on today's $0.0515. Momentum favours further upside here.
In 2029, MTX is projected to trade between $0.0761 and $0.144, averaging $0.101 — a potential gain of +96% from today's $0.0515. That is up +23% on the projected 2028 average. Buyers look set to stay in control over this stretch.
MediTechX's 2030 outlook centres on $0.1502, within a $0.1108 to $0.2198 range. That is up +49% on the projected 2029 average. That marks a +192% change versus current levels. Momentum favours further upside here.
By 2031, MTX could reach as high as $0.2807, with a base case around $0.1877 and support toward $0.1358 — roughly +264% from $0.0515. Buyers look set to stay in control over this stretch.
Expect MTX to range from $0.1142 to $0.2453 through 2032. The $0.1608 average target implies a +212% move from current prices. That is -14% versus the projected 2031 average. Momentum favours further upside here.
The MTX price prediction for 2033 points to an average of $0.2195 (low $0.1533, high $0.3407) — a potential gain of +326% on today's $0.0515. Buyers look set to stay in control over this stretch.
In 2034, MTX is projected to trade between $0.2324 and $0.5338, averaging $0.3383 — a potential gain of +557% from today's $0.0515. That is up +54% on the projected 2033 average. Momentum favours further upside here.
MediTechX's 2035 outlook centres on $0.2776, within a $0.1878 to $0.4447 range. That is -18% versus the projected 2034 average. That marks a +439% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, MTX could reach as high as $1.00, with a base case around $0.5871 and support toward $0.3703 — roughly +10.4x from $0.0515. Momentum favours further upside here.
Expect MTX to range from $0.5452 to $1.83 through 2050. The $0.9761 average target implies a +17.9x move from current prices. That is up +66% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MTX today (≈ 19,411.444988 MTX) could be worth
$18,946.59
+$17,946.59 (+1795%) by 2050 · US Dollar
Based on the average projected MTX price of $0.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MTXwould be worth at today's price.
$1,000 invested in MTX on Mar 1, 2026 (≈ 19,487.759486 MTX) would be worth
$1,003.93
+$3.93 (+0.4%) today · 1.00× · US Dollar
Based on a MTX entry price of $0.051314 vs. today's $0.051516.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.051199 | $1,006.18 | +0.6% |
| 1 month ago | $0.050854 | $1,013.02 | +1.3% |
| All time ago | $0.051314 | $1,003.93 | +0.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MTX forecast.
Our base-case forecast reaches $0.10 around 2029.
Implied market cap at $0.10: $2.7M
The multi-year outlook shows a bullish trajectory with clear milestones in key years. In 2030, the forecast offers an average price of $0.1688, with a min of $0.1243 and a max of $0.2475, and a projected ROI of 227.8%, signaling strong upside potential within a broader bullish context. By 2040, the average price is projected at $0.6029, with a min of $0.3798 and a max of $1.03, and a projected ROI of 1070.6%, underscoring a substantial expansion if the trajectory plays out.
In 2050, the forecast envisions an average price of $0.9625, with a min of $0.5371 and a max of $1.80, and a projected ROI of 1768.8%, reflecting a pronounced long-term upside potential. Across these years, sentiment is consistently BULLISH, suggesting growing market enthusiasm and demand as the asset evolves. These are estimates, not guarantees, and outcomes depend on future market conditions and adoption of the MTX ecosystem.
Tap a question to reveal the answer.
Avg $0.1688, min $0.1243, max $0.2475; ROI 227.8%; sentiment BULLISH.
The forecast shows NEUTRAL in 2026 and BULLISH from 2027 onward, with rising averages to 2030 ($0.1688 avg) and beyond. Projected ROI grows from 65.3% (2027) to 1768.8% (2050), but these are estimates and not guarantees.
2030 max is $0.2475, just below $0.25. However, 2033 max is $0.3864, meaning higher levels are possible in the forecast window.
Current price is $0.0515. Market cap is $1.39M.
2026 avg $0.0515; 2027 avg $0.0851; 2028 avg $0.075; 2029 avg $0.1015; 2030 avg $0.1688.
MediTechX Community Discussion
0Share your MediTechX price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.